FDA Panel Backs First mRNA Flu Vaccine for Adults 50+

An FDA advisory committee unanimously recommended approval for the first mRNA flu vaccine, marking a major breakthrough that could save thousands of lives and make flu shots faster to produce.

The same technology that powered COVID vaccines is now set to revolutionize flu prevention.